{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:16:13Z","timestamp":1790806573998,"version":"4.1.0"},"reference-count":23,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Medtronic Diabetes"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate glycemic metrics and insulin delivery during real-world use of the MiniMed 780G (MM780G) system on days when users did not administer boluses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Global CareLink personal data of consenting MM780G users (N = 369,467) uploaded from 2 January 2020 to 31 March 2025 were analyzed. Among these individuals, 54,553 users experienced \u226510 days without any user-initiated boluses. Evaluated key metrics included time in range (TIR; 70\u2013180 mg\/dL), time below range (TBR; &amp;lt;70 mg\/dL), time above range (&amp;gt;180 mg\/dL), the glucose management indicator (GMI), and total insulin delivered. These were analyzed for the overall population who did not initiate boluses and for those who used and did not use recommended optimal settings (ROS; defined as a 100 mg\/dL glucose target and a 2-h active insulin time). Subgroup analyses were conducted by age (\u226415 or &amp;gt;15 years) and diabetes type (type 1 or 2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>On days when boluses were missed, ROS users had a mean sensor glucose (SG) of 149.2 mg\/dL, with mean TIR, TBR, and GMI of 76.3%, 0.8%, and 6.9%, respectively, whereas non-ROS users had a mean SG of 159.7 mg\/dL with mean TIR, TBR, and GMI of 69.3%, 0.9%, and 7.1%, respectively. ROS use was associated with more individuals achieving consensus TIR, TBR, and GMI goals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>These data demonstrate effective glycemic control with the MM780G system on days when some users did not initiate boluses. A greater proportion of real-world users achieved glycemic goals when ROS were used.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc25-2124","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:46:35Z","timestamp":1767793595000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":5,"title":["MiniMed 780G Advanced Hybrid Closed-Loop System Use During Days Without User-Initiated Boluses"],"prefix":"10.2337","volume":"49","author":[{"given":"Fang","family":"Niu","sequence":"first","affiliation":[{"name":"Medtronic Diabetes , Northridge, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Liu","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes , Northridge, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Yovanovich","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes , Northridge, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3546-3385","authenticated-orcid":false,"given":"Robert A.","family":"Vigersky","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes , Northridge, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Shin","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes , Northridge, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8436-671X","authenticated-orcid":false,"given":"Jennifer J.F.","family":"McVean","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes , Northridge, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"2026061811422385300_B1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/cd20-0117","article-title":"Exploring the burden of mealtime insulin dosing in adults and children with type 1 diabetes","volume":"39","author":"Lane","year":"2021","journal-title":"Clin Diabetes"},{"key":"2026061811422385300_B2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/dia.2021.0164","article-title":"Missed and mistimed insulin doses in people with diabetes: a systematic literature review","volume":"23","author":"Robinson","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026061811422385300_B3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/jhn.12561","article-title":"Carbohydrate knowledge, lifestyle and insulin: an observational study of their association with glycaemic control in adults with type 1 diabetes","volume":"31","author":"Smythe","year":"2018","journal-title":"J Hum Nutr Diet"},{"key":"2026061811422385300_B4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2337\/dc13-1867","article-title":"Depression in adults in the T1D Exchange Clinic Registry","volume":"37","author":"Trief","year":"2014","journal-title":"Diabetes Care"},{"key":"2026061811422385300_B5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2147\/PPA.S87935","article-title":"Adherence to insulin treatment in insulin-na\u00efve type 2 diabetic patients initiated on different insulin regimens","volume":"9","author":"Yavuz","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"2026061811422385300_B6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/dia.2024.0022","article-title":"Impact of missed and late meal boluses on glycemic outcomes in automated insulin delivery-treated children and adolescents with type 1 diabetes: a two-center, population-based cohort study","volume":"26","author":"Laugesen","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026061811422385300_B7","doi-asserted-by":"crossref","first-page":"A259","DOI":"10.2337\/db18-992-P","article-title":"Late and missed meal boluses with multiple daily insulin injections","volume":"67","author":"Norlander","year":"2018","journal-title":"Diabetes"},{"key":"2026061811422385300_B8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1399-5448.2008.00462.x","article-title":"Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes","volume":"10","author":"Olinder","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"2026061811422385300_B9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/dia.2022.0518","article-title":"Hybrid closed loop overcomes the impact of missed or suboptimal meal boluses on glucose control in children with type 1 diabetes compared to sensor-augmented pump therapy","volume":"25","author":"Coutant","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026061811422385300_B10","doi-asserted-by":"crossref","first-page":"1141085","DOI":"10.3389\/fendo.2023.1141085","article-title":"Missed meal boluses and poorer glycemic control impact on neurocognitive function may be associated with white matter integrity in adolescents with type 1 diabetes","volume":"14","author":"Litmanovitch","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026061811422385300_B11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s13410-024-01310-y","article-title":"Factors affecting the prolongation of glycemic time in range among children with type 1 diabetes using continuous glucose monitoring systems: a case control study","volume":"44","author":"Emilia","year":"2024","journal-title":"Int J Diabetes Dev Ctries"},{"key":"2026061811422385300_B12","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.2337\/dc09-S318","article-title":"Insulin therapy for type 2 diabetes","volume":"32","author":"Swinnen","year":"2009","journal-title":"Diabetes Care"},{"key":"2026061811422385300_B13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and glycemic outcomes during the MiniMed\u2122 advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026061811422385300_B14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dia.2021.0203","article-title":"Real-world performance of the MiniMed\u2122 780G system: first report of outcomes from 4120 users","volume":"24","author":"Da Silva","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026061811422385300_B15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(22)00212-1","article-title":"Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study","volume":"10","author":"Choudhary","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026061811422385300_B16","doi-asserted-by":"crossref","first-page":"19322968251318373","DOI":"10.1177\/19322968251318373","article-title":"Performance of an automated insulin delivery system in people living with type 2 diabetes and insulin resistance: first real-world evidence in 26 427 users","author":"Thijs","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"2026061811422385300_B17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/dia.2024.0586","article-title":"Safety and effectiveness of MiniMedTM 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes","volume":"27","author":"Bhargava","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"2026061811422385300_B18","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1111\/dom.15868","article-title":"Generating real-world evidence on diabetes technology using the CareLink Personal data management system","volume":"26","author":"van den Heuvel","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026061811422385300_B19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/dia.2023.0139","article-title":"Unannounced meal challenges using an advanced hybrid closed-loop system","volume":"25","author":"Shalit","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026061811422385300_B20","doi-asserted-by":"crossref","first-page":"951-P","DOI":"10.2337\/db24-951-P","article-title":"The t:slim X2 with Control-IQ technology overcomes missed boluses for moderate meals","volume":"73","author":"Fu","year":"2024","journal-title":"Diabetes"},{"key":"2026061811422385300_B21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.21037\/tp-24-114","article-title":"Clinical relevance of short-term glycemic variability in children and adolescents with type 1 diabetes: a narrative review","volume":"13","author":"Bombaci","year":"2024","journal-title":"Transl Pediatr"},{"key":"2026061811422385300_B22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026061811422385300_B23","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/3\/419\/852772\/dc252124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/3\/419\/852772\/dc252124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:42:33Z","timestamp":1781797353000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/3\/419\/164061\/MiniMed-780G-Advanced-Hybrid-Closed-Loop-System"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,1,7]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc25-2124","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}